News
02-26-2014, 05:22 AM
QIAGEN N.V. today announced the commercial launch in India of its careHPV™ Test, the only molecular diagnostic for high-risk human papillomavirus (HPV) designed to screen women in settings with limited healthcare infrastructure, such as areas lacking electricity, water or laboratories.
More... (http://www.news-medical.net/news/20140226/QIAGEN-launches-careHPV-Test-in-India-for-prevention-of-cervical-cancer-among-women.aspx)
More... (http://www.news-medical.net/news/20140226/QIAGEN-launches-careHPV-Test-in-India-for-prevention-of-cervical-cancer-among-women.aspx)